Gennex Laboratories Calls Shareholder Meeting for Director Approval

Gennex Laboratories Ltd. has announced it will convene an Extraordinary General Meeting (EGM) on May 12, 2026. The main purpose of this meeting is for shareholders to cast their vote on the approval of Ms. Khushbu Kachhawa's appointment as a Non-Executive Independent Woman Director.

Ms. Kachhawa initially joined the company's board as an Additional Director on February 14, 2026, following the resignation of Ms. Shilpa Bung. This EGM is being held to formally confirm her directorship in line with company procedures.

The company is holding this meeting to ensure full compliance with SEBI's Listing Obligations and Disclosure Requirements regulations. Maintaining a board composed of independent directors is considered a key component of strong corporate governance.

To facilitate the EGM and the voting process, NSDL has been appointed to manage the proceedings and offer e-voting services to shareholders. Ms. Sweety Kapoor will serve as the Scrutinizer for the vote count.

The outcome of the shareholder vote is a critical step. Any significant opposition could potentially create challenges or delays in the finalization of Ms. Kachhawa's appointment.

Investors and stakeholders will be closely observing the EGM results. Gennex Laboratories will issue a formal announcement post-meeting to confirm the outcome and its adherence to regulatory mandates.